NCT04368468View on ClinicalTrials.gov

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

January 31, 2021

Conditions
Triple Negative Breast Cancer
Interventions
OTHER

biomarker evolution

analysis of a list of biomarkers on triple negative breast tumors samples before and after neoadjuvant therapy

Trial Locations (1)

31059

Institut claudius regaud, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT04368468 - Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC | Biotech Hunter | Biotech Hunter